Stay updated with breaking news from Mark Courey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This news from the FDA followed a resubmission after the FDA’s complete response letter for the P2X3 receptor antagonist’s use in refractory chronic cough and unexplained cough.
Dr. David Miramontes contracted a rare form of cancer three years ago.
Tarrytown, NY (PRWEB) October 21, 2021 -- With an ever-increasing demand for specialized Ear, Nose, and Throat care in the Hudson Valley, ENT and Allergy